{
  "ticker": "JNJ",
  "target_date": "2025-08-07",
  "actual_date": "2025-08-07",
  "collected_at": "2025-12-08T12:06:49.181015",
  "price": {
    "open": 168.85,
    "high": 169.29,
    "low": 167.62,
    "close": 169.20579528808594,
    "volume": 9315900,
    "change_1d_pct": 0.55,
    "change_7d_pct": 2.03,
    "change_30d_pct": 12.64
  },
  "technicals": {
    "rsi_14": 67.67,
    "sma_20": 163.61,
    "sma_50": 156.74,
    "macd": 3.572,
    "macd_signal": 3.393,
    "macd_histogram": 0.179,
    "bb_upper": 173.14,
    "bb_lower": 154.09,
    "price_vs_sma20_pct": 3.42,
    "price_vs_sma50_pct": 7.96,
    "volume_ratio": 0.98
  },
  "fundamentals": {
    "market_cap": 488918253568,
    "pe_ratio": 19.587837,
    "forward_pe": 19.144339,
    "price_to_book": 6.159286,
    "price_to_sales": 5.305736,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.35,
    "pct_from_52w_low": 44.25
  },
  "macro": {
    "spy": {
      "price": 630.5,
      "change_1d_pct": -0.08,
      "change_7d_pct": -0.35
    },
    "vix": {
      "level": 16.57,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.24
    },
    "dollar_index": {
      "level": 98.4
    },
    "gold": {
      "price": 3400.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Genmab raises full-year outlook, shares rise",
      "source": "Yahoo",
      "datetime": 1754585315,
      "summary": "Investing.com -- Genmab raised its full-year revenue and profit guidance on Thursday, driven by stronger-than-expected royalties from key partner drugs.",
      "url": "https://finnhub.io/api/news?id=479680a0c71618a0997680d2f2495e0fd6d78bdc9adfd392c4720d3c238d2939"
    },
    {
      "headline": "Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?",
      "source": "Yahoo",
      "datetime": 1754574002,
      "summary": "Here is how Encompass Health (EHC) and Johnson & Johnson (JNJ) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=d57ff8fcf81e6dfb3cb447f1a69a04455bf279b4a638c372a82a56f5395db41c"
    },
    {
      "headline": "United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda",
      "source": "Yahoo",
      "datetime": 1754570460,
      "summary": "The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a CAGR of 4.86% (2025-2033). Growth is driven by rising chronic diseases, demand for innovative medicines, and advanced biotech solutions. High R&D investments in oncology, neurolo",
      "url": "https://finnhub.io/api/news?id=c5faab32289036b61d1de41f603a0cb2c73c4612692dcf7386f42a8f151806d8"
    },
    {
      "headline": "Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical",
      "source": "Yahoo",
      "datetime": 1754569860,
      "summary": "The Saudi Arabia OTC Artificial Tears Market is projected to reach USD 79.09 million by 2033, growing at a CAGR of 4.22% from 2025. Contributing factors include a rising elderly population, increased incidence of dry eye syndrome, and greater use of digital screens. Enhanced awareness of eye health,",
      "url": "https://finnhub.io/api/news?id=09e8791d380db68c19a93903274690cc09b7fe501a69fed3d31134b08af60fcd"
    },
    {
      "headline": "August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys",
      "source": "SeekingAlpha",
      "datetime": 1754569431,
      "summary": "Discover the top Dow dividend stocks for steady gains by 2026.",
      "url": "https://finnhub.io/api/news?id=5b4324cf7aa0db1844e537f7ec31acf7b22ccb8eb46fc4995dc453357313aa09"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}